Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMT for CRE Colonization Eradication
NCT04146337Phase 3Completed
- Sponsor
- Rambam Health Care Campus
- Start
- Oct 2020
- Primary completion
- Dec 2021
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 3 trial of allogeneic fecal microbiota in Enterobacteriaceae colonization, sponsored by Rambam Health Care Campus. Started Oct 2020; status: completed.
02
Drugs
allogeneic fecal microbiota
03
Conditions
Enterobacteriaceae colonization
Beyond the preview
Go deeper on NCT04146337.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04146337.